Dorn Spinal Therapy

Spine Healing Therapy

Get Instant Access

Abbott FV, Hong Y, Blier P: Persisting sensitization of the behavioural response to formalin-induced injury through activation of serotonin2A receptors. Neuroscience 77:575-584, 1997 Abernethy DR, Greenblatt DJ, Steel K, et al: Impairment of hepatic drug oxidation by propoxyphene. Ann Intern Med 97:223-224, 1982 Ansari A: The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature. Harv Rev Psychiatry 7:257-277, 2000 Arnold LM, Lu Y, Crofford LJ, et al: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50:2974-2984, 2004 Baba H, Shimoji K, Yoshimura M: Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 1): effects on axon terminals of GABAergic and glycinergic neurons. Anesthesiology 92:473-484, 2000 Bartusch SL, Sanders BJ, D'Alessio JG, et al: Clonazepam for the treatment of lancinating phantom limb pain. Clin J Pain 12:59-62, 1996 Beaver WT, Wallenstein SL, Houde RW, et al: A comparison of the analgesic effects of methotrimeprazine and morphine in patients with cancer. Clin Pharmacol Ther

7:436-466, 1966

Bendtsen L, Jensen R: Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62:1706-1711, 2004 Bouckoms A: Psychiatric aspects of pain in the critically ill, in Problems in Critical

Care. Edited by Wise MG. Philadelphia, PA, JB Lippincott, 1988 Bouckoms AJ, Litman RE: Clonazepam in the treatment of neuralgic pain syndrome.

Psychosomatics 26:933-936, 1985 Browning CH: Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. Int J Psychiatry Med 26:25-34, 1996 Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69:751754, 1985

Buckley FP, Sizemore WA, Charlton JE: Medication management in patients with chronic nonmalignant pain: a review of the use of a drug withdrawal protocol.

Pain 26:153-165, 1986 Cassem NH: Pain (Current Topics in Medicine, Vol. 2), in Scientific American Medicine.

Edited by Rubenstein E, Federman DD. New York, Scientific American, 1989 Ciccone DS, Just N, Bandilla EB, et al: Psychological correlates of opioid use in patients with chronic nonmalignant pain: a preliminary test of the downhill spiral hypothesis. J Pain Symptom Manage 20:180-192, 2000

Collins SL, Moore RA, McQuay HJ, et al: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 20:449-458, 2000 Dellemijn PL, Fields HL: Do benzodiazepines have a role in chronic pain management?

Pain 57:137-152, 1994 Diamond S, Freitag FG: The use of fluoxetine in the treatment of headache. Clin J

Pain 5:200-201, 1989 Dillon P, Copeland J, Jansen K: Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 69:23-28, 2003 Eide PK, Jorum E, Stubhaug A, et al: Relief of post-herpetic neuralgia with the N-methyl-aspartic acid receptor antagonist ketamine: a double-blind cross-over comparison with morphine and placebo. Pain 58:347-354, 1994 Eisenach JC, DuPen SL, Dubois M, et al: Epidural clonidine analgesia for intractable cancer pain. Pain 61:391-399, 1995 Eisenberg E, Kleiser A, Dotort A, et al: The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. Eur J Pain 2:321-327, 1998 Elliott K, Hynansky A, Inturrisi CE: Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59:361-368, 1994 Enarson MC, Hays H, Woodroffe MA: Clinical experience with oral ketamine. J Pain

Symptom Manage 17:384-386, 1999 Ernst E: Herb-drug interactions : potentially important but woefully under-researched.

Eur J Clin Pharmacol 56:523-524, 2000 Ettinger AB, Portenoy RK: The use of corticosteroids in the treatment of symptoms associated with cancer. J Pain Symptom Manage 3:99-103, 1988 Fields HL, Basbaum AI: Central nervous system mechanisms of pain modulation, in Textbook of Pain, 4th Edition. Edited by Wall PD, Melzack R. Edinburgh, Scotland, Churchill Livingstone, 1999, pp 309-329 Finlayson RE, Maruta T, Morse RM, et al: Substance dependence and chronic pain: profile of 50 patients treated in an alcohol and drug dependence unit. Pain 26:167174, 1986

Fishbain DA, RosomoffHL, RosomoffRS: Detoxification ofnonopiate drugs in the chronic pain setting and clonidine opiate detoxification. Clin J Pain 8:191-203, 1992 Fishbain DA, Cutler RB, Lewis J, et al: Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review. Pain Med 5:359365, 2004

Fisher K, Coderre TJ, Hagen NA: Targeting the N-methyl-D-aspartate receptor for chronic pain management: preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 20:358-373, 2000

Forrest WH, Brown BW, Brown CR, et al: Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 296:712-715, 1977 Fox A, Kesingland A, Gentry C, et al: The role of central and peripheral cannabinoidi receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92:91-100, 2001 Frampton JE, Scott LJ: Pregabalin in the treatment of painful diabetic neuropathy.

Drugs 64:2813-2820, 2004 Galer BS: Neuropathic pain of peripheral origin: advances in pharmacologic treatment.

Neurology 45 (suppl 9):17-25, 1995 Gerner P, Mujtaba M, Sinnott CJ, et al: Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology 94:661-667, 2001 Goadsby PJ, Lipton RB, Ferrari MD: Drug therapy: migraine—current understanding and treatment. N Engl J Med 346:257-270, 2002 Goldstein DJ, Lu Y, Detke MJ, et al: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109-118, 2005 Gomez-Perez FJ, Rull JA, Dies H, et al: Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study. Pain

23:395-400, 1985

Goodnick PJ, Breakstone K, Khumar A, et al: Nefazodone in diabetic neuropathy: response and biology. Psychosom Med 62:599-600, 2000 Gorman AL, Elliott KJ, Inturrisi CE: The d- and l-isomers of methadone bind to the noncompetitive site on the N-methyl-D-aspartate (NMDA) receptor in rat fore-brain and spinal cord. Neurosci Lett 223:5-8, 1997 Gratz SS, Simpson GM: MAOI-narcotic interactions (letter). J Clin Psychiatry 54:439, 1993 Inturrisi CE: Role of opioid analgesics. Am J Med 77(suppl):27-37, 1984 Jaffe JH, Martin WR: Opioid analgesics and antagonists, in The Pharmacological Basis of Therapeutics. Edited by Gilman AG, Rall TW, Nies AS, et al. New York, Pergamon, 1990

Jiang HK, Chang DM: Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports. Clin Rheumatol 18:339-345, 1999 Kapelushnik J, Koren G, Solh H, et al: Evaluating the efficacy of EMLA in alleviating pain associated with lumbar puncture; comparison of open and double-blinded protocols in children. Pain 42:31-34, 1990 Kaufman DW, Kelly JP, Rosenberg L, et al: Recent patterns of medication use in the ambulatory adult population ofthe United States—the Slone Survey. JAMA287:337-344, 2002

Kawasaki Y, Kumamoto E, Furue H, et al: a2 adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons. Anesthesiology 98:682-689, 2003

Keeri-Szanto M: The mode of action of promethazine in potentiating narcotic drugs.

Br J Anaesth 46:918-924, 1974 Khojainova N, Santiago-Palma J, Kornick C, et al: Olanzapine in the management of cancer pain. J Pain Symptom Manage 23:346-350, 2002 Khoromi S, Patsalides A, Parada S, et al: Topiramate in chronic lumbar radicular pain.

J Pain 6:829-836, 2005 Khurana RC: Treatment of painful diabetic neuropathy with trazodone (letter). JAMA 250:1392, 1983

King SA, Strain J: Benzodiazepine use by chronic pain patients. Clin J Pain 6:143-147, 1990 Kishore-Kumar R, Schafer SC, Lawlor BA, et al: Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain

37:223-227, 1989

Krell HV, Leuchter AF, Cook IA, et al: Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 46:379-384, 2005 Larijani GE, Goldberg ME, Hojat M, et al: Modafinil improves recovery after general anesthesia. Anesth Analg 98:976-981, 2004 Larson AA, Takemori AE: Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sci 21:1807-1812, 1977 Laska EM, Sunshine A, Mueller F, et al: Caffeine as an analgesic adjuvant. JAMA 251:17111718, 1984

Lee RL, Spencer PSJ: Effect of tricyclic antidepressants on analgesic activity in laboratory animals. Postgrad Med J 56 (suppl 1):19-24, 1980 Leo RJ: Treatment considerations in neuropathic pain. Curr Treat Options Neurol 8:389-400, 2006

Leo RJ: Pain disorders, in The American Psychiatric Publishing Textbook of Clinical Psychiatry, 5th Edition. Edited by Hales RE, Yudofsky SC, Gabbard GO. Washington, DC, American Psychiatric Publishing, 2008 Leo RJ, Baer D: Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics 46:503-507, 2005 Leo RJ, Brooks VL: Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Curr Opin Investig Drugs 7:637-642, 2006 Leo RJ, Narendran R: Anticonvulsant use in the treatment of bipolar disorder: a primer for primary care physicians. Prim Care Companion J Clin Psychiatry 1:74-84, 1999 Leo RJ, Narendran R, DeGuiseppe B: Methadone detoxification of tramadol dependence. J Subst Abuse Treat 19:297-299, 2000 Maciewicz R, Bouckoms A, Martin JB: Drug therapy of neuropathic pain. Clin J Pain 1:39-49, 1985

Maltbie AA, Cavenar JO, Sullivan JL, et al: Analgesia and haloperidol: a hypothesis.

J Clin Psychiatry 40:323-326, 1979 Massie MJ (ed): Pain: What Psychiatrists Need to Know (Review of Psychiatry Series, Vol 19; Oldham JM and Riba MB, series eds). Washington, DC, American Psychiatric Press, 2000

Matchar DB, Young WB, Rosenberg JH, et al: Evidence-based guidelines for migraine headache in the primary care setting: pharmacologic management of acute attacks. 2002. Available at: Accessed February 26, 2007. Mathew NT, Tietjen GE, Lucker C: Serotonin syndrome complicating migraine phar-

macotherapy. Cephalalgia 16:323-327, 1996 Max MB, Lynch SA, Muir J, et al: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992 McEvoy G (ed): American Hospital Formulary Service (AHFS) Drug Information

2006. Bethesda, MD, American Society of Health-System Pharmacists, 2006 McLean M: Clinical pharmacokinetics ofgabapentin. Neurology 44 (suppl 5):17-22, 1994 McNairy SL, Maruta T, Ivnik RJ, et al: Prescription medication dependence and neuropsychologic function. Pain 18:169-177, 1984 McQuay H, Carroll D, Jadad AR, et al: Anticonvulsant drugs for management of pain:

a systematic review. BMJ 311:1047-1052, 1995 McQuay HJ, Moore RA: Methods of therapeutic trials, in Textbook of Pain, 4th Edition. Edited by Wall PD, Melzack R. Edinburgh, Churchill Livingstone, 1999, pp 1125-1138

Nemmani KVS, Mogil JS: Serotonin-GABA interactions in the modulation of mu-

and kappa-opioid analgesia. Neuropharmacology 44:304-310, 2003 Novak V, Kanard R, Kissel JT, et al: Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res 11:357-361, 2001 Pappagallo M: Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine. Clin Ther 25:2506-2538, 2003 Pick CG, Paul D, Eison MS, et al: Potentiation of opioid analgesia by the antidepressant nefazodone. Eur J Pharmacol 211:375-381, 1992 Portenoy RK: Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 11:203-217, 1996 Portenoy RK, Hagen NA: Breakthrough pain: definition, prevalence and characteristics. Pain 41:273-281, 1990 Putnam GP, O'Quinn S, Bolden-Watson CP, et al: Migraine polypharmacy and the toler-ability of sumatriptan: a large-scale, prospective study. Cephalalgia 19:668-675, 1999 Ragheb MA, Powell AL: Failure of sulindac to increase serum lithium levels. J Clin Psychiatry 47:33-34, 1986

Reissig JE, Rybarczyk AM: Pharmacologic treatment of opioid-induced sedation in chronic pain. Ann Pharmacother 39:727—731, 2005 Remillard G: Oxcarbazepine and intractable trigeminal neuralgia. Epilepsia 35:528529, 1994

Rowbotham MC, Goli V, Kunz NR, et al: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110:697-706, 2004

Rumore MM, Schlichting DA: Clinical efficacy of antihistamines as analgesics. Pain 25:7-22, 1986

Samborski W, Lezanska-Szpera M, Rybakowski JK: Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 37:168-170, 2004 Sang CN, Booher S, Gilron I, et al: Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 96:1053-1061, 2002 Saper JR, Silberstein SD, Lake AE, et al: Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 34:497-502, 1994 Saper JR, Lake AE, Tepper SJ: Nefazodone for chronic daily headache prophylaxis: an open-label study. Headache 41:465-474, 2001 Schreiber S, Backer MM, Weizman R, et al: Augmentation of opioid induced anti-nociception by the atypical antipsychotic drug risperidone in mice. Neurosci Lett 228:25-28, 1997

Schreiber S, Getslev V, Backer MM, et al: The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency. Pharmacol Biochem Behav 64:75-80, 1999 Semenchuk MR, Sherman S, Davis B: Double-blind, randomized trial of bupropion

SR for the treatment of neuropathic pain. Neurology 57:1583-1588, 2001 Shimoyama N, Shimoyama M, Elliott KJ, et al: D-Methadone is antinociceptive in the rat formalin test. J Pharmacol Exp Ther 283:648-652, 1997 Silberstein SD, Young WB, Hopkins MM, et al: Olanzapine in the treatment of refractory migraine and chronic daily headache. Cephalalgia 20:382-383, 2000 Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389-400, 1999 Sindrup SH, Gram LF, Brosen K, et al: The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42:135-144, 1990

Sindrup SH, Grodum E, Gram LF, et al: Concentration-response relationship in par-oxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study. Ther Drug Monit 13:408-414, 1991

Sindrup SH, Bach FW, Madsen C, et al: Venlafaxine versus Imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60:1284—1289, 2003 Snow V, Weiss K, Wall EM, et al: Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 137:840—849, 2002

Solaro C, Uccelli MM, Brichetto G, et al: Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage 21:367—368, 2001 Sommer BR, Petrides G: A case of baclofen-induced psychotic depression. J Clin Psychiatry 53:211-212, 1992 Stambaugh JE, Wainer IW: Drug interaction: meperidine and chlorpromazine, a toxic combination. J Clin Pharmacol 21:140-146, 1981 Sternbach H: The serotonin syndrome. Am J Psychiatry 148:705-713, 1991 Svendsen KB, Jensen TS, Bach FW: Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329:253-260, 2004 Swerdlow M: Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 7:51-82, 1984

Taiwo YO, Fabian A, Pazoles CJ, et al: Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 21:329-337, 1985 Turner JA, Deyo RA, Loeser JD, et al: The importance of placebo effects in pain treatment and research. JAMA 271:1609-1614, 1994 Ventafridda V, Caraceni A, Saita L, et al: Trazodone for deafferentation pain: comparison with amitriptyline. Psychopharmacology (Berl) 95 (suppl):S44-S49, 1988 Vitton O, Gendreau M, Gendreau J, et al: A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol Clin Exp

19 (suppl 1):S27-S35, 2004 Weissman DE, Haddox JD: Opioid pseudoaddiction: an iatrogenic syndrome. Pain 36:363-366, 1989

Wise MG, Rundell JR: Pain and analgesics, in Clinical Manual of Psychosomatic Medicine: A Guide to Consultation-Liaison Psychiatry. Washington, DC, American Psychiatric Publishing, 2005, pp 228-229 Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al: Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 73:223-230, 1997 Zijlstra TR, Barendregt PJ, van de Laar MAF: Venlafaxine in fibromyalgia: results of a randomized, placebo-controlled, double-blind trial (abstract). Arthritis Rheum

Was this article helpful?

0 0


Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook

Post a comment